In a dramatic twist of corporate fortunes, View Inc., a pioneering smart-glass manufacturer once pegged at a $2 billion valuation, finds itself grappling with dire financial straits. The company, known for its revolutionary automatically tinting glass, is currently navigating turbulent waters, potentially leading to a restructuring of debt or even an asset sale, as revealed […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Signup for news and special announcements!
You have successfully joined our subscriber list.
Enlaza Therapeutics, a venture-backed La Jolla biotech with a Vertex Pharmaceuticals collaboration...
ByThe RegistryNovember 14, 2026Mosaic Development has asked Los Angeles to carve a Venice single-family parcel...
ByThe RegistryNovember 14, 2026After 50 years at the controls, 83-year-old Buddy Brundo is asking $15...
ByThe RegistryNovember 14, 2026A local private investor completing a 1031 exchange paid $14.3 million for...
ByThe RegistryNovember 14, 2026Error: Contact form not found.